Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms

por Georgescu, Maria T., Moorehead, Paul C., van Velzen, Alice S., Nesbitt, Kate, Reipert, Birgit M., Steinitz, Katharina N., Schuster, Maria, Hough, Christine, Lillicrap, David
Publicado 2018

Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study

por van Velzen, Alice S., Eckhardt, Corien L., Peters, Marjolein, Oldenburg, Johannes, Cnossen, Marjon, Liesner, Ri, Morfini, Massimo, Castaman, Giancarlo, McRae, Simon, van der Bom, Johanna G., Fijnvandraat, Karin
Publicado 2020

Desmopressin in moderate hemophilia A patients: a treatment worth considering

por Loomans, Janneke I., Kruip, Marieke J.H.A., Carcao, Manuel, Jackson, Shannon, van Velzen, Alice S., Peters, Marjolein, Santagostino, Elena, Platokouki, Helen, Beckers, Erik, Voorberg, Jan, van der Bom, Johanna G., Fijnvandraat, Karin
Publicado 2018

Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study

por Abdi, Amal, Eckhardt, Corien L., van Velzen, Alice S., Vuong, Caroline, Coppens, Michiel, Castaman, Giancarlo, Hart, Dan P., Hermans, Cedric, Laros‐van Gorkom, Britta, Leebeek, Frank W. G., Mancuso, Maria Elisa, Mazzucconi, Maria G., McRae, Simon, Oldenburg, Johannes, Male, Christoph, van der Bom, Johanna G., Fijnvandraat, Karin, Gouw, Samantha C.
Publicado 2021